Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Assessing diabetes risk in cirrhosis patients before and after liver transplant

Official title: Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant

Run by University of Chicago · NCT06950788 · Data updated 2026-11-12

This study is trying to find out what factors might lead to diabetes in adults with liver cirrhosis before and after they get a liver transplant.

More Transplant trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedMarch 12, 2024
Main results expectedJune 2027
Study endsJanuary 2031
Registry record updatedMay 7, 2026
Trial IDNCT06950788 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with a diagnosis of cirrhosis who are being evaluated for liver transplantation.

Probably not a fit

Patients with a history of type 2 diabetes diagnosed more than five years ago will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify risk factors for developing diabetes in adult patients with cirrhosis who are being evaluated for liver transplantation. Participants will undergo various assessments, including continuous glucose monitoring, wrist actigraphy, and oral glucose tolerance tests, both prior to and following their liver transplant. The study will track these patients over a five-year period to evaluate the long-term outcomes related to diabetes development. The goal is to determine if specific laboratory and functional tests can predict the onset of diabetes after transplantation.

Why it matters

Potential benefit: If successful, this study could help identify patients at high risk for diabetes after liver transplantation, allowing for targeted interventions.

How similar studies have gone: While there have been studies on diabetes risk in transplant patients, this specific approach using advanced monitoring techniques is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients presenting to liver transplant clinic with a diagnosis of cirrhosis.
* Age \>18 yrs.
* Ability to understand and sign written consent form, or have a legally-authorized representative or proxy who can be approached for consent

Exclusion Criteria:

* Patients without consent
* Patients with implantable cardioverter defibrillator devices or automated implantable cardioverter defibrillator devices will be excluded from the bio-electrical impedance analysis portion of the measurements.
* Patients with unremovable electrical medical devices or devices that cannot turn off will be excluded from the bio-electrical impedance analysis measurements
* Pregnant patients
* Incarcerated patients
* Patients with a history of type 2 diabetes mellitus diagnosed \> 5 years ago will be excluded from the Oral Glucose Tolerance Test portion of the study

Where it's running

  • University of Chicago Medical Center
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.